Catamaran Bio is a biotechnology company that specializes in allogeneic immune cell therapies. Founded in 2020, Catamaran Bio is backed by investors that include Sofinnova Partners, Lightstone Ventures, SV Health Investors, Takeda Ventures, and Astellas Venture Management and is headquartered in Cambridge.
FOUNDED:
2020
INDUSTRY:
Biopharma, Biotechnology
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
